EPISODE · Nov 11, 2021 · 6 MIN
Tapan Kadia, MD, Highlights Venetoclax Plus Chemotherapy for AML, MDS
from Oncology Learning Network · host HMP Global
Tapan M. Kadia, MD, highlights a phase 2 trial on venetoclax plus intensive chemotherapy in patients with newly diagnosed AML or MDS.
Embed this episode
Ready to play
Tapan Kadia, MD, Highlights Venetoclax Plus Chemotherapy for AML, MDS
0:00
6:08
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Learning Network?
This episode is 6 minutes long.
When was this Oncology Learning Network episode published?
This episode was published on November 11, 2021.
Can I download this Oncology Learning Network episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!